Previous Close | 9.40 |
Open | 9.40 |
Bid | 7.35 |
Ask | 10.45 |
Strike | 85.00 |
Expire Date | 2024-05-17 |
Day's Range | 9.40 - 9.40 |
Contract Range | N/A |
Volume | |
Open Interest | 9 |
Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe. "As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.